Patents by Inventor David Bryce
David Bryce has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230172975Abstract: The present invention relates to novel gold-platinum based bi-metallic nanocrystal suspensions that have nanocrystal surfaces that are substantially free from organic or other impurities or films associated with typical chemical reductants/stabilizers and/or raw materials used in nanoparticle formation processes. Specifically, the surfaces are “clean” relative to the surfaces of metal-based nanoparticles made using chemical reduction (and other) processes that require organic (or other) reductants and/or surfactants to grow (and/or suspend) metal nanoparticles from metal ions in a solution. The invention includes novel electrochemical manufacturing apparatuses and techniques for making the bi-metallic nanocrystal suspensions. The techniques do not require the use or presence of chlorine ions/atoms and/or chlorides or chlorine-based materials for the manufacturing process/final suspension.Type: ApplicationFiled: March 30, 2022Publication date: June 8, 2023Applicant: GR Intellectual Reserve, LLCInventors: Adam R. Dorfman, David A. Bryce, Maxwell A. Grace, D. Kyle Pierce, Mikhail Merzliakov, Mark G. Mortenson
-
Patent number: 11487646Abstract: Systems, methods, and machine-readable instructions stored on machine-readable media are disclosed for adjusting a time limit for a test based on one or more indications of availability. A test is executed, wherein the test includes a time limit. A determination is made that the time limit is exceeded. In response, the time limit is adjusted based on one or more indications of availability.Type: GrantFiled: March 1, 2019Date of Patent: November 1, 2022Assignee: Red Hat, Inc.Inventors: Steven Francis Best, David Bryce Arcari
-
Publication number: 20210397442Abstract: A method includes, receiving a first version of a software patch for an application. The method further includes receiving a second version of the software patch, the second version being associated with an upstream version of the application. The method further includes, comparing the first version of the software patch with the second version of the software patch, the comparing accounting for differences between the first version of the software patch and the second version of the software patch that result from differences between the application and the upstream version of the application. The method further includes, in response to comparing, tagging the first version of the software patch as a match when there are no differences other than the differences between the first version of the software patch and the second version of the software patch that result from differences between the application and the upstream version of the application.Type: ApplicationFiled: June 23, 2020Publication date: December 23, 2021Inventors: Steven Francis Best, David Bryce Arcari
-
Publication number: 20210392899Abstract: This invention relates generally to novel methods and novel devices for the continuous manufacture of nanoparticles, microparticles and nanoparticle/liquid solution(s). The nanoparticles (and/or micron-sized particles) comprise a variety of possible compositions, sizes and shapes. The particles (e.g., nanoparticles) are caused to be present (e.g., created) in a liquid (e.g., water) by, for example, preferably utilizing at least one adjustable plasma (e.g., created by at least one AC and/or DC power source), which plasma communicates with at least a portion of a surface of the liquid. At least one subsequent and/or substantially simultaneous adjustable electrochemical processing technique is also preferred. Multiple adjustable plasmas and/or adjustable electrochemical processing techniques are preferred. The continuous process causes at least one liquid to flow into, through and out of at least one trough member, such liquid being processed, conditioned and/or effected in said trough member(s).Type: ApplicationFiled: April 12, 2021Publication date: December 23, 2021Applicant: Clene NanomedicineInventors: David K. Pierce, Mark G. Mortenson, David A. Bryce
-
Patent number: 11204759Abstract: A method includes, receiving a first version of a software patch for an application. The method further includes receiving a second version of the software patch, the second version being associated with an upstream version of the application. The method further includes, comparing the first version of the software patch with the second version of the software patch, the comparing accounting for differences between the first version of the software patch and the second version of the software patch that result from differences between the application and the upstream version of the application. The method further includes, in response to comparing, tagging the first version of the software patch as a match when there are no differences other than the differences between the first version of the software patch and the second version of the software patch that result from differences between the application and the upstream version of the application.Type: GrantFiled: June 23, 2020Date of Patent: December 21, 2021Assignee: RED HAT, INC.Inventors: Steven Francis Best, David Bryce Arcari
-
Publication number: 20210361699Abstract: The present invention relates to novel gold nanocrystals and nanocrystal shape distributions that have surfaces that are substantially free from organic impurities or films. Specifically, the surfaces are “clean” relative to the surfaces of gold nanoparticles made using chemical reduction processes that require organic reductants and/or surfactants to grow gold nanoparticles from gold ions in solution. The invention includes novel electrochemical manufacturing apparatuses and techniques for making the gold-based nanocrystals. The invention further includes pharmaceutical compositions thereof and the use of the gold nanocrystals or suspensions or colloids thereof for the treatment or prevention of diseases or conditions for which gold therapy is already known and more generally for conditions resulting from pathological cellular activation, such as inflammatory (including chronic inflammatory) conditions, autoimmune conditions, hypersensitivity reactions and/or cancerous diseases or conditions.Type: ApplicationFiled: April 13, 2021Publication date: November 25, 2021Applicant: Clene Nanomedicine, Inc.Inventors: Mark Gordon Mortenson, D. Kyle Pierce, David A. Bryce, Reed N. Wilcox, Anthony Lockett, Mikhail Merzliakov
-
Publication number: 20210236542Abstract: The present invention relates to novel gold nanocrystals and nanocrystal shape distributions that have surfaces that are substantially free from organic impurities or films. Specifically, the surfaces are “clean” relative to the surfaces of gold nanoparticles made using chemical reduction processes that require organic reductants and/or surfactants to grow gold nanoparticles from gold ions in solution. The invention includes novel electrochemical manufacturing apparatuses and techniques for making the gold-based nanocrystals. The invention further includes pharmaceutical compositions thereof and the use of the gold nanocrystals or suspensions or colloids thereof for the treatment or prevention of diseases or conditions for which gold therapy is already known and more generally for conditions resulting from pathological cellular activation, such as inflammatory (including chronic inflammatory) conditions, autoimmune conditions, hypersensitivity reactions and/or cancerous diseases or conditions.Type: ApplicationFiled: April 6, 2021Publication date: August 5, 2021Applicant: Clene Nanomedicine, Inc.Inventors: Mark Gordon Mortenson, D. Kyle Pierce, David A. Bryce, Reed N. Wilcox, Anthony Lockett, Mikhail Merzliakov
-
Patent number: 11054356Abstract: A particle characterisation apparatus comprising: a light source for illuminating a sample with a light beam; a detector arranged to detect scattered light from the interaction of the light beam with the sample; a focus tuneable lens arranged to collect the scattered light for the detector from a scattering volume and/or to direct the light beam into the sample, a sample holder with an opposed pair of electrodes and configured to hold a sample in position in a measurement volume between the pair of electrodes such that a planar surface of the sample is aligned orthogonally to the electrode surfaces, the planar surface adjacent to the scattering volume, wherein adjustment of the focus tuneable lens results in adjustment of the relative position of the planar surface and the scattering volume by moving the scattering volume.Type: GrantFiled: October 24, 2017Date of Patent: July 6, 2021Assignee: Malvern Panalytical LimitedInventors: Jason Cecil William Corbett, David Bryce
-
Patent number: 11000042Abstract: This invention relates generally to novel methods and novel devices for the continuous manufacture of nanoparticles, microparticles and nanoparticle/liquid solution(s). The nanoparticles (and/or micron-sized particles) comprise a variety of possible compositions, sizes and shapes. The particles (e.g., nanoparticles) are caused to be present (e.g., created) in a liquid (e.g., water) by, for example, preferably utilizing at least one adjustable plasma (e.g., created by at least one AC and/or DC power source), which plasma communicates with at least a portion of a surface of the liquid. At least one subsequent and/or substantially simultaneous adjustable electrochemical processing technique is also preferred. Multiple adjustable plasmas and/or adjustable electrochemical processing techniques are preferred. The continuous process causes at least one liquid to flow into, through and out of at least one trough member, such liquid being processed, conditioned and/or effected in said trough member(s).Type: GrantFiled: August 31, 2018Date of Patent: May 11, 2021Inventors: David K. Pierce, Mark G. Mortenson, David A. Bryce
-
Publication number: 20210124310Abstract: A solid state light shadow clock including construction of multiple light sources about the perimeter illuminated inward to cast shadows displaying apparent rotation about the center at the speed of clock hands; at a speed of one revolution per hour, at the speed of one revolution per twelve hours, and at the speed of one revolution per minute; a circumferential inward facing arrangement of light emitting devices to cast shadows at various lengths and color combinations. The clock comprises radial shadows cast in representation of the arms of a clock. The shadow clock display may be incorporated in devices ranging in size from portable devices to large public displays.Type: ApplicationFiled: October 7, 2020Publication date: April 29, 2021Inventor: DAVID BRYCE TURNER
-
Patent number: 10980832Abstract: The present invention relates to novel gold nanocrystals and nanocrystal shape distributions that have surfaces that are substantially free from organic impurities or films. Specifically, the surfaces are “clean” relative to the surfaces of gold nanoparticles made using chemical reduction processes that require organic reductants and/or surfactants to grow gold nanoparticles from gold ions in solution. The invention includes novel electrochemical manufacturing apparatuses and techniques for making the gold-based nanocrystals. The invention further includes pharmaceutical compositions thereof and the use of the gold nanocrystals or suspensions or colloids thereof for the treatment or prevention of diseases or conditions for which gold therapy is already known and more generally for conditions resulting from pathological cellular activation, such as inflammatory (including chronic inflammatory) conditions, autoimmune conditions, hypersensitivity reactions and/or cancerous diseases or conditions.Type: GrantFiled: August 8, 2019Date of Patent: April 20, 2021Assignee: Clene Nanomedicine, Inc.Inventors: Mark Gordon Mortenson, D. Kyle Pierce, David A. Bryce, Reed N. Wilcox, Anthony Lockett, Mikhail Merzliakov
-
Publication number: 20210052638Abstract: This invention relates generally to novel methods and novel devices for the continuous manufacture of nanoparticles, microparticles and nanoparticle/liquid solution(s). The nanoparticles (and/or micron-sized particles) comprise a variety of possible compositions, sizes and shapes. The particles (e.g., nanoparticles) are caused to be present (e.g., created and/or the liquid is predisposed to their presence (e.g., conditioned)) in a liquid (e.g., water) by, for example, preferably utilizing at least one adjustable plasma (e.g., created by at least one AC and/or DC power source), which plasma communicates with at least a portion of a surface of the liquid. At least one subsequent and/or substantially simultaneous adjustable electrochemical processing technique is also preferred. Multiple adjustable plasmas and/or adjustable electrochemical processing techniques are preferred.Type: ApplicationFiled: October 9, 2019Publication date: February 25, 2021Applicant: Clene Nanomedicine, Inc.Inventors: David Kyle Pierce, Mark G. Mortenson, David A. Bryce
-
Publication number: 20200278919Abstract: Systems, methods, and machine-readable instructions stored on machine-readable media are disclosed for adjusting a time limit for a test based on one or more indications of availability. A test is executed, wherein the test includes a time limit. A determination is made that the time limit is exceeded. In response, the time limit is adjusted based on one or more indications of availability.Type: ApplicationFiled: March 1, 2019Publication date: September 3, 2020Inventors: Steven Francis Best, David Bryce Arcari
-
Publication number: 20200188429Abstract: The present invention relates to novel gold nanocrystals and nanocrystal shape distributions that have surfaces that are substantially free from organic impurities or films. Specifically, the surfaces are “clean” relative to the surfaces of gold nanoparticles made using chemical reduction processes that require organic reductants and/or surfactants to grow gold nanoparticles from gold ions in solution. The invention includes novel electrochemical manufacturing apparatuses and techniques for making the gold-based nanocrystals. The invention further includes pharmaceutical compositions thereof and the use of the gold nanocrystals or suspensions or colloids thereof for the treatment or prevention of diseases or conditions for which gold therapy is already known and more generally for conditions resulting from pathological cellular activation, such as inflammatory (including chronic inflammatory) conditions, autoimmune conditions, hypersensitivity reactions and/or cancerous diseases or conditions.Type: ApplicationFiled: August 8, 2019Publication date: June 18, 2020Applicant: Clene Nanomedicine, Inc.Inventors: Mark Gordon Mortenson, D. Kyle Pierce, David A. Bryce, Reed N. Wilcox, Anthony Lockett, Mikhail Merzliakov
-
Publication number: 20200166446Abstract: A particle characterisation apparatus comprising: a light source for illuminating a sample with a light beam; a detector arranged to detect scattered light from the interaction of the light beam with the sample; a focus tuneable lens arranged to collect the scattered light for the detector from a scattering volume and/or to direct the light beam into the sample, a sample holder with an opposed pair of electrodes and configured to hold a sample in position in a measurement volume between the pair of electrodes such that a planar surface of the sample is aligned orthogonally to the electrode surfaces, the planar surface adjacent to the scattering volume, wherein adjustment of the focus tuneable lens results in adjustment of the relative position of the planar surface and the scattering volume by moving the scattering volume.Type: ApplicationFiled: October 24, 2017Publication date: May 28, 2020Applicant: Malvern Panalytical LimitedInventors: Jason Cecil William CORBETT, David BRYCE
-
Patent number: 10449217Abstract: The present invention relates to novel gold nanocrystals and nanocrystal shape distributions that have surfaces that are substantially free from organic impurities or films. Specifically, the surfaces are “clean” relative to the surfaces of gold nanoparticles made using chemical reduction processes that require organic reductants and/or surfactants to grow gold nanoparticles from gold ions in solution. The invention includes novel electrochemical manufacturing apparatuses and techniques for making the gold-based nanocrystals. The invention further includes pharmaceutical compositions thereof and the use of the gold nanocrystals or suspensions or colloids thereof for the treatment or prevention of diseases or conditions for which gold therapy is already known and more generally for conditions resulting from pathological cellular activation, such as inflammatory (including chronic inflammatory) conditions, autoimmune conditions, hypersensitivity reactions and/or cancerous diseases or conditions.Type: GrantFiled: March 21, 2017Date of Patent: October 22, 2019Assignee: Clene Nanomedicine, Inc.Inventors: Mark Gordon Mortenson, D. Kyle Pierce, David A. Bryce, Reed N. Wilcox, Anthony Lockett, Mikhail Merzliakov
-
Patent number: 10441608Abstract: This invention relates generally to novel methods and novel devices for the continuous manufacture of nanoparticles, microparticles and nanoparticle/liquid solution(s). The nanoparticles (and/or micron-sized particles) comprise a variety of possible compositions, sizes and shapes. The particles (e.g., nanoparticles) are caused to be present (e.g., created and/or the liquid is predisposed to their presence (e.g., conditioned)) in a liquid (e.g., water) by, for example, preferably utilizing at least one adjustable plasma (e.g., created by at least one AC and/or DC power source), which plasma communicates with at least a portion of a surface of the liquid. At least one subsequent and/or substantially simultaneous adjustable electrochemical processing technique is also preferred. Multiple adjustable plasmas and/or adjustable electrochemical processing techniques are preferred.Type: GrantFiled: June 30, 2016Date of Patent: October 15, 2019Assignee: Clene Nanomedicine, Inc.Inventors: David Kyle Pierce, Mark G. Mortenson, David A. Bryce
-
Patent number: 10365198Abstract: A particle characterization apparatus comprising: a light source for illuminating a sample with a light beam; a detector arranged to detect scattered light from the interaction of the light beam with the sample; and a focus tuneable lens arranged to collect the scattered light for the detector from a scattering volume and/or to direct the light beam into the sample.Type: GrantFiled: March 9, 2017Date of Patent: July 30, 2019Assignee: Malvern Panalytical LimitedInventors: Jason Cecil William Corbett, David Bryce
-
Publication number: 20190059386Abstract: This invention relates generally to novel methods and novel devices for the continuous manufacture of nanoparticles, microparticles and nanoparticle/liquid solution(s). The nanoparticles (and/or micron-sized particles) comprise a variety of possible compositions, sizes and shapes. The particles (e.g., nanoparticles) are caused to be present (e.g., created) in a liquid (e.g., water) by, for example, preferably utilizing at least one adjustable plasma (e.g., created by at least one AC and/or DC power source), which plasma communicates with at least a portion of a surface of the liquid. At least one subsequent and/or substantially simultaneous adjustable electrochemical processing technique is also preferred. Multiple adjustable plasmas and/or adjustable electrochemical processing techniques are preferred. The continuous process causes at least one liquid to flow into, through and out of at least one trough member, such liquid being processed, conditioned and/or effected in said trough member(s).Type: ApplicationFiled: August 31, 2018Publication date: February 28, 2019Applicant: Clene Nanomedicine, Inc.Inventors: David K. Pierce, Mark G. Mortenson, David A. Bryce
-
Patent number: 10092007Abstract: This invention relates generally to novel methods and novel devices for the continuous manufacture of nanoparticles, microparticles and nanoparticle/liquid solution(s). The nanoparticles (and/or micron-sized particles) comprise a variety of possible compositions, sizes and shapes. The particles (e.g., nanoparticles) are caused to be present (e.g., created) in a liquid (e.g., water) by, for example, preferably utilizing at least one adjustable plasma (e.g., created by at least one AC and/or DC power source), which plasma communicates with at least a portion of a surface of the liquid. At least one subsequent and/or substantially simultaneous adjustable electrochemical processing technique is also preferred. Multiple adjustable plasmas and/or adjustable electrochemical processing techniques are preferred. The continuous process causes at least one liquid to flow into, through and out of at least one trough member, such liquid being processed, conditioned and/or effected in said trough member(s).Type: GrantFiled: August 11, 2017Date of Patent: October 9, 2018Assignee: Clene Nanomedicine, Inc.Inventors: David K. Pierce, Mark G. Mortenson, David A. Bryce